摘要
目的 探讨2型糖尿病患者甲状腺激素水平变化及临床意义.方法 对126例2型糖尿病患者血清游离甲状腺素（free thyroxine,FT4）、游离三碘甲状腺原氨酸（free triiodothyronine,FT3）及促甲状腺激素（thyroid-stimulating hormone,TSH）等甲状腺激素水平进行检测,并与健康对照组的100例健康受试者的甲状腺激素水平进行比较分析.结果 糖尿病组患者血清FT3水平（4.31 ±0.56） pmol/L显著低于健康对照组（5.52±0.68） pmol/L,组间差异具有统计学意义（P＜0.05）；血清FT4（12.86±1.39） pmol/L、TSH（1.76±0.15）μIU/mL水平略低于健康对照组（13.27±1.72） pmol/L、（1.85±0.20）μIU/mL,组间差异无统计学意义（P＞0.05）.结论 检测糖尿病患者血清甲状腺激素水平对患者病情评估及治疗均具有重要的临床意义.
Objective To investigate the changes and clinical significance of the serum levels of thyroid hormone in the patients with type 2 diabetes mellitus.Methods The serum levels of free thyroxine （FT4）,free triiodothyronine （FT3） and thyroid stimulating hormone （TSH） were detected in 126 cases with type 2 diabetes mellitus,and were compared with 100 healthy subjects in the healthy control group.Results The serum level of FT3 （4.31 ± 0.56） pmol/L in the patients with diabetes mellitus group was lower than that （5.52 ± 0.68） pmol/L of the healthy control group with statistically significant difference （P ＜ 0.05）; the serum levels of FT4 （12.86-± 1.39） pmol/L,TSH （1.76 ± 0.15） μ IU/ml were lower than those of the healthy control group （13.27 ±-1.72） pmol/L,（1.85 ± 0.20） μ IU/mL without statistical significant difference （P ＞ 0.05）.Conclusion There are important clinical significances in detecting the serum levels of thyroid hormone for the assessment and treatment in patients with diabetes mellitus.
出处
《国际医药卫生导报》
2013年第22期3474-3476,共3页
International Medicine and Health Guidance News
关键词
2型糖尿病
甲状腺激素
血清
Type 2 diabetes mellitus
Thyroid hormone
Serum
